|
|
Vaccine Detail
|
Autologous EBV-Transformed B Lymphoblastoid-Tumor Fusion Cell Vaccine |
| Vaccine Information |
- Vaccine Name: Autologous EBV-Transformed B Lymphoblastoid-Tumor Fusion Cell Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0007292
- Type: Recombinant vector vaccine
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Host Species as Laboratory Animal Model: Human
- Description: A cell-based vaccine composed of autologous tumor cells fused with Epstein-Barr virus-transformed B-lymphoblastoid cells. Upon administration, this vaccine may stimulate a cytotoxic T cell response against tumor cells, resulting in tumor cell lysis. (NCIT_C48377).
|
| Host Response |
|
|
| References |
NCIT_C48377: [https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48377]
|
|
